Merck has been quietly making moves worldwide to position molnupiravir as the standard early-onset, orally-administered antiviral treatment for COVID-19. TrialSite has reported that Merck’s teams…
Story 1: Mansoura University Ivermectin-based Study Results in Superior Viral Clearance & Peer Review Status in Journal of Medical Virology: Back in May 2020, TrialSite…
Back in May 2020, TrialSite announced the study titled a pilot clinical trial led by Egypt’s Mansoura University, located in the middle of the Nile…
A principal investigator with Egypt’s Benha University and team recently concluded a clinical trial titled ‘Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of…
Egypt reports via its Minister of Higher Education and Scientific Research that that influential Arabic nation will conduct two Phase COVID-19 vaccine clinical trials in…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
